Severe to profound hearing loss seen in 18% of male germ cell tumor survivors.
Researchers observe no significant survival difference for stage IIb patients.
Estimated 33% of overall risk is genetic; certain types of cancer have additional risk.
Study shows that 81% of scrotal ultrasounds for pain demonstrate normal or benign findings.
Risk of testicular cancer, non-Hodgkin's lymphoma, all cancers up vs. men who have undergone vasectomy.
Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.
A history of testicular cancer was associated with a greater likelihood of prostate cancer overall and intermediate- or high-risk disease.
Risk factors include male gender, distant disease, increasing age, race/ethnicity
Studies show integrated program effective for depression in patients with cancer.
Late, advanced stage relapse rarely seen and are treatable with standard therapy.
Increase in incidence of testicular germ cell tumors in Hispanic adolescents and young adults.
Increasing health insurance coverage and access to usual source of care necessary to meet targets.
Seventeen percent of Americans think that there is nothing people can do to change their risk.
Death from PCa is down 45% from peak rates, but more than 29,000 men are projected to die from PCa in 2014.
Innovative approaches offer the potential for effective treatments to limited target areas with improved side effect profiles.
Only 9.5% of the study participants were told about the possibilities of overdiagnosis and overtreatment by their physicians.
Most want to be told of screening harms, but only 9.5 percent informed about overdiagnosis, overtx.
Giving men a single dose of chemotherapy along with radiotherapy may help improve the effectiveness of treatment.
Azoospermic men may be nearly three times as likely to receive a diagnosis of cancer as men in the overall population.
Study attributes this to greater understanding of pathology, increased surveillance.
The malignancy is three times more likely to develop in boys with cryptorchidism.
Those who had ever smoked marijuana were almost twice as likely as non-users of marijuana to develop the disease.
The relapse-free survival at 10 years was 83% and 54% for stage IIA and IIB patients, respectively.
Risk highest for nonseminoma and mixed histology tumors.
Researchers believe their findings suggest post-natal risk factors modify testicular cancer risk.
Long-term serum levels of residual platinum correlate with the severity of neurotoxicity five to 20 years after chemotherapy in testicular cancer (TC) survivors, even after adjusting for initial cisplatin dose, according to a study published online in the Journal of Clinical Oncology.
Frequent CT scanning for testicular cancer surveillance appears to be associated with secondary malignancies.
CHICAGO—Testicular cancer survivors treated with chemotherapy and radiotherapy are at increased risk for cardiovascular disease (CVD), researchers reported at the American Society of Clinical Oncology annual meeting. These patients also are at higher risk for hypertension and diabetes.
Marijuana use may increase a man's risk of testicular cancer, particularly the nonseminona or mixed-histology form, according to a study published in Cancer (2009; published online ahead of print).
Renal and Urology News Articles
- Hypogonadism in Male HD Patients Linked to Poor ESA Response
- Risk Factors for Post-TPTx Severe Hypocalcemia Identified
- Elevated CRP Linked With CKD Risk in Rheumatoid Arthritis
- Losartan Reduces Aldosterone in Hypertension Without Sleep Apnea
- 10-Year Mortality for Localized PCa Does Not Differ by Treatment Choice
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)